11 results
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... sarahthelyon #Diabetes ... #Medications #pharmacology ... #pathophysiology ... #endocrinology
Diabetes Insipidus vs Syndrome of Inappropriate ADH (SIADH) - Comparison Table

Diabetes Insipidus - Inadequate ADH
SIADH -
Diabetes Insipidus ... Excess ADH #Diabetes ... Comparison #Table #Pathophysiology ... Signs #Symptoms #Diagnosis ... #Endocrinology
Pathogenesis and Pathophysiology of Diabetic Ketoacidosis (DKA)

DKA is a result of an absolute or relative insulin
of Diabetic Ketoacidosis ... driven by insulin) shifts ... #Pathophysiology ... #DKA #Diabetes ... #Endocrinology
Stages in the Development of Diabetes Type 1

#Diabetes #Type1 #TypeI #DM1 #Stages #Development #Pathophysiology #Timeline #Diagnosis
Development of Diabetes ... Type 1 #Diabetes ... #Development #Pathophysiology ... #Timeline #Diagnosis ... #Endocrinology
Clavicular Fracture: Pathogenesis and clinical findings

Group I (69%) - Middle third (mid-shaft)
Group II (29%) - Distal
Clavicular Fracture ... Middle third (mid-shaft ... and the site of fracture ... #Grading #Diagnosis ... #pathophysiology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... • Euglycemic diabetic ... amputation and bone fractures ... #Summary #DM2 #diabetes ... #endocrinology
Mechanisms of Drug-Induced Hyperkalemia 
 • Direct renin inhibitor (Aliskiren)
 • Renin release inhibition (NSAIDs, Beta-Blockers)
• Increased EC shift ... #differential #diagnosis ... #pathophysiology ... #pharmacology #
Erectile Dysfunction: Pathogenesis

Erectile Dysfunction - Persistent or recurrent inability to achieve an erection sufficient to achieve
and rigidity Endocrinologic ... hyperlipidemia, diabetes ... (penile artery diameter ... #Dysfunction #Pathophysiology ... #Urology #Diagnosis
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... level < 200 mg/dL Pathophysiology ... #Euglycemic #Diabetic ... Ketoacidosis #EuDKA #diagnosis ... #management #endocrinology
Refeeding Syndrome Overview

What Is It?
	• Electrolyte/fluid shifts caused by initiation of nutrition in severely malnourished patient.
Electrolyte/fluid shifts ... • These shifts ... Poorly controlled diabetes ... #Differential #Diagnosis ... #Pathophysiology